UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA

Clinical cancer research, 2016-12, Vol.22 (23), p.5772-5782

2016

Volltextzugriff (PDF)

Gene signature of antigen processing and presentation machinery predicts response to checkpoint blockade in non-small cell lung cancer (NSCLC) and melanoma

Journal for immunotherapy of cancer, 2020-10, Vol.8 (2), p.e000974

2020

Volltextzugriff (PDF)

Function of Human Tumor-Infiltrating Lymphocytes in Early-Stage Non-Small Cell Lung Cancer

Cancer immunology research, 2019-06, Vol.7 (6), p.896-909

2019

Volltextzugriff (PDF)

Combining radiomic phenotypes of non-small cell lung cancer with liquid biopsy data may improve prediction of response to EGFR inhibitors

Scientific reports, 2021-05, Vol.11 (1), p.9984-9984, Article 9984

2021

Volltextzugriff (PDF)

Development of a robust radiomic biomarker of progression-free survival in advanced non-small cell lung cancer patients treated with first-line immunotherapy

Scientific reports, 2022-06, Vol.12 (1), p.9993-9993, Article 9993

2022

Volltextzugriff (PDF)

Predictive Signatures for Responses to Checkpoint Blockade in Small-Cell Lung Cancer in Second-Line Therapy Do Not Predict Responses in First-Line Patients

Cancers, 2024-08, Vol.16 (16), p.2795

2024

Volltextzugriff (PDF)

Phenotypic and functional analysis of malignant mesothelioma tumor-infiltrating lymphocytes

Oncoimmunology, 2019-09, Vol.8 (9), p.e1638211-e1638211

2019

Volltextzugriff (PDF)

Could DNA Fragments Be the Key to Early Detection of Lung Cancer?

American journal of respiratory and critical care medicine, 2023-05, Vol.207 (9), p.1120-1122

2023

Volltextzugriff (PDF)

Impact of Interobserver Variability in Manual Segmentation of Non-Small Cell Lung Cancer (NSCLC) Applying Low-Rank Radiomic Representation on Computed Tomography

Cancers, 2021-11, Vol.13 (23), p.5985

2021

Volltextzugriff (PDF)

Racial Disparities in 30-Day Outcomes Following Index Admission for COVID-19

Frontiers in medicine, 2021-11, Vol.8, p.750650-750650

2021

Volltextzugriff (PDF)

Molecular response assessment using circulating tumor DNA (ctDNA) in advanced solid tumors

British journal of cancer, 2023-12, Vol.129 (12), p.1893-1902

2023

Volltextzugriff (PDF)

Plasma Cell‐Free DNA Genotyping: From an Emerging Concept to a Standard‐of‐Care Tool in Metastatic Non‐Small Cell Lung Cancer

The oncologist (Dayton, Ohio), 2021-10, Vol.26 (10), p.e1812-e1821

2021

Volltextzugriff (PDF)

Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2017-04, Vol.106, p.1-7

2017

Volltextzugriff (PDF)

Gene signatures of tumor inflammation and epithelial-to-mesenchymal transition (EMT) predict responses to immune checkpoint blockade in lung cancer with high accuracy

Lung cancer (Amsterdam, Netherlands), 2020-01, Vol.139, p.1-8

2020

Volltextzugriff (PDF)

Hepatocytes direct the formation of a pro-metastatic niche in the liver

Nature (London), 2019-03, Vol.567 (7747), p.249-252

2019

Volltextzugriff (PDF)

Plasma Tumor Mutation Burden and Response to Pembrolizumab-Response

Clinical cancer research, 2021-03, Vol.27 (5), p.1581-1581

2021

Volltextzugriff (PDF)

Baseline Plasma Tumor Mutation Burden Predicts Response to Pembrolizumab-based Therapy in Patients with Metastatic Non-Small Cell Lung Cancer

Clinical cancer research, 2020-05, Vol.26 (10), p.2354-2361

2020

Volltextzugriff (PDF)

Transcriptional profiling of single tumour cells from pleural effusions reveals heterogeneity of epithelial to mesenchymal transition and extra‐cellular matrix marker expression

Clinical and translational medicine, 2022-07, Vol.12 (7), p.e888-n/a

2022

Volltextzugriff (PDF)

Plasma Tumor Mutation Burden and Response to Pembrolizumab-Response

Clinical cancer research, 2020-07, Vol.26 (13), p.3492-3492

2020

Volltextzugriff (PDF)

Radiologic Pseudoprogression during Anti–PD-1 Therapy for Advanced Non–Small Cell Lung Cancer

Journal of thoracic oncology, 2018-07, Vol.13 (7), p.978-986

2018

Volltextzugriff (PDF)

A 53-Year-Old Man Presents to the ED With Shortness of Breath, Cough, and Fever

Chest, 2021-02, Vol.159 (2), p.e107-e113

2021

Volltextzugriff (PDF)

Red blood cells function as reservoirs of tumor DNA

American journal of physiology. Lung cellular and molecular physiology, 2024-05, Vol.326 (5), p.L646-L650

2024

Volltextzugriff (PDF)

Neutrophil content predicts lymphocyte depletion and anti-PD1 treatment failure in NSCLC

JCI insight, 2019-12, Vol.4 (24)

2019

Volltextzugriff (PDF)

Are radiomic signatures ready for incorporation in the clinical pipeline?

Translational lung cancer research, 2023-09, Vol.12 (9), p.1845-1849

2023

Volltextzugriff (PDF)

1 – 25 von 1.644

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieThe Journal Of Urology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.472)
Mit Volltextzugriff
(1.406)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA

Gene signature of antigen processing and presentation machinery predicts response to checkpoint blockade in non-small cell lung cancer (NSCLC) and melanoma

Function of Human Tumor-Infiltrating Lymphocytes in Early-Stage Non-Small Cell Lung Cancer

Combining radiomic phenotypes of non-small cell lung cancer with liquid biopsy data may improve prediction of response to EGFR inhibitors

Development of a robust radiomic biomarker of progression-free survival in advanced non-small cell lung cancer patients treated with first-line immunotherapy

Predictive Signatures for Responses to Checkpoint Blockade in Small-Cell Lung Cancer in Second-Line Therapy Do Not Predict Responses in First-Line Patients

Phenotypic and functional analysis of malignant mesothelioma tumor-infiltrating lymphocytes

Could DNA Fragments Be the Key to Early Detection of Lung Cancer?

Impact of Interobserver Variability in Manual Segmentation of Non-Small Cell Lung Cancer (NSCLC) Applying Low-Rank Radiomic Representation on Computed Tomography

Racial Disparities in 30-Day Outcomes Following Index Admission for COVID-19

Molecular response assessment using circulating tumor DNA (ctDNA) in advanced solid tumors

Plasma Cell‐Free DNA Genotyping: From an Emerging Concept to a Standard‐of‐Care Tool in Metastatic Non‐Small Cell Lung Cancer

Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer

Gene signatures of tumor inflammation and epithelial-to-mesenchymal transition (EMT) predict responses to immune checkpoint blockade in lung cancer with high accuracy

Hepatocytes direct the formation of a pro-metastatic niche in the liver

Plasma Tumor Mutation Burden and Response to Pembrolizumab-Response

Baseline Plasma Tumor Mutation Burden Predicts Response to Pembrolizumab-based Therapy in Patients with Metastatic Non-Small Cell Lung Cancer

Transcriptional profiling of single tumour cells from pleural effusions reveals heterogeneity of epithelial to mesenchymal transition and extra‐cellular matrix marker expression

Plasma Tumor Mutation Burden and Response to Pembrolizumab-Response

Radiologic Pseudoprogression during Anti–PD-1 Therapy for Advanced Non–Small Cell Lung Cancer

Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung Cancer

A 53-Year-Old Man Presents to the ED With Shortness of Breath, Cough, and Fever

Red blood cells function as reservoirs of tumor DNA

Neutrophil content predicts lymphocyte depletion and anti-PD1 treatment failure in NSCLC

Are radiomic signatures ready for incorporation in the clinical pipeline?

Aktive Filter

Suchergebnisse filtern